Emyria (ASX:EMD)
ASX announcement history & article coverage
Transparent by design.
Announcments by Emyria (ASX:EMD) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Emyria Depression Program Shows Positive Results
Emyria reports encouraging early results in treatment-resistant depression program
Emyria Confirms NSW Workforce Ahead of Clinic Opening
Emyria trains NSW clinicians ahead of Sydney Empax clinic opening in Q3 2026
Emyria Company Update - Video Presentation
Emyria Company Update Presentation
Emyria updates on clinic progress, market opportunity, and funding in psychedelic-assisted therapy
Notification of cessation of securities - EMD
Change of Director's Interest Notice x 2
Notification regarding unquoted securities - EMD
Application for quotation of securities - EMD
TGA Update to Accelerate Empax Therapist Recruitment
TGA expands therapist eligibility to accelerate Emyria's Empax clinic recruitment
Emyria Activates First Victorian Empax Clinic
Emyria Launches First Victorian Empax Clinic, Expands Mental Health Treatment Network
March Quarter Investor Video Presentation
Emyria reports $1.2M revenue growth, clinic expansions, and advances in psychedelic therapy programs
Results of General Meeting
Emyria Extends National Expansion into New South Wales
Emyria Expands National Mental Health Clinic Network into New South Wales with Matilda Healthcare Partnership
March 2026 Quarterly Activities Report and Appendix 4C
Emyria reports $1.2m revenue, expands national clinics, launches global partnership program
Ignite Investment Summit Singapore Presentation
Emyria Launches Global Partnership Program
Emyria launches global clinical services platform for psychedelic drug sponsors
